SCHEMBL6905937

SCHEMBL6905937

CCOc1ccc(C(C(=O)NS(N)(=O)=O)N(c2ccccc2)c2ccc(C#N)cc2)cc1OCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.39
NPSR1 Q6W5P4 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
F7 P08709 6/20 0.38
F3 P13726 4/20 0.38
F2 P00734 3/20 0.37
F10 P00742 3/20 0.37
PRSS1 P07477 3/20 0.37
GAA P10253 1/20 0.37
ALDH1A1 P00352 2/20 0.36
TRPV4 Q9HBA0 1/20 0.36
PRSS2 P07478 1/20 0.36
PRSS3 P35030 1/20 0.36
PDE4A P27815 3/20 0.36
PDE4B Q07343 3/20 0.36
PDE4C Q08493 3/20 0.36
PDE4D Q08499 3/20 0.36
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5422452 0.79 F7 (0.51) F7F3F2F10PRSS1
SCHEMBL8300552 0.70 F7 (0.49) F7F3F2F10PRSS1
SCHEMBL8299398 0.70 F7 (0.47) F7F3F2F10PRSS1
SCHEMBL5882260 0.69 F7 (0.58) NPSR1SMN1; SMN2F7F3F2
SCHEMBL5044585 0.67 F7 (0.75) F7F3F2F10PRSS1
SCHEMBL5139581 0.67 F7 (0.52) F7F3F2F10PRSS1
SCHEMBL5883389 0.67 F7 (0.56) NPSR1SMN1; SMN2F7F3F2
SCHEMBL5882092 0.67 F7 (0.72) NPSR1SMN1; SMN2F7F3F2
SCHEMBL5883639 0.66 F7 (0.55) NPSR1SMN1; SMN2F7F3F2
SCHEMBL7150980 0.66 F7 (0.74) F7F3F2F10PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040242585-A1 Acylsulfamide inhibitors of factor VIIa GENENTECH, INC. 2004-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242585-A1 Acylsulfamide inhibitors of factor VIIa TFPI, TFPI2, HABP2 TNF 2990/4885NPSR1 2025/4885SMN1; SMN2 2585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.